TMCI

Insider trade Purchase by Treace John T. (Chief Executive Officer)

17h ago

Insider trade Purchase by Treace John T. (Chief Executive Officer)

4d ago

SEC filing TMCI Elects Directors, Approves Executive Compensation, Ratifies Grant Thornton LLP, 32.8M Votes For Say-on-Pay, 47.9M For Auditor Ratification

12d ago

News Treace Medical (TMCI) Q2 Revenue Up 7%

14d ago

Insider trade Purchase by John T. Treace (Chief Executive Officer)

18d ago

Insider trade Purchase by John T. Treace (Chief Executive Officer)

18d ago

Insider trade Purchase by John T. Treace (Chief Executive Officer)

18d ago

News Treace reaffirms 2026 revenue of $202M-$212M while targeting $300M TAM expansion in Q3 launches

25d ago

SEC filing TMCI Preliminary Q1 Revenue $47.1M, Cash $51.9M, Updates 2026 Guidance to $202M-$212M, CEO John T. Treace

54d ago

News Treace Medical signals 2026 revenue target of $200M–$212M while expanding comprehensive bunion solutions

94d ago

News Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M

95d ago

SEC filing TMCI Reports $62.5M Q4 Rev, $212.7M FY Rev, $(9.4M) Q4 Net Loss, 3,337 Surgeons Active

95d ago

News Treace announces preliminary Q4 revenue between $62.1M to $62.5M

140d ago